KAI1/CD82与肝癌关系的研究进展
摘要
KAI1/CD82为肿瘤转移抑制基因,定位于11 P11.2~1 3,属于TM4SF家族成员,主要影响细胞间及细胞与细胞外基质的信号传导。KAI1/CD82表达下调与肝细胞癌浸润转移相关。
出处
《中国医学文摘(肿瘤学)》
2006年第1期70-71,73,共3页
Journal of Chinese Medical Abstracts·Oncology
基金
广西壮族自治区卫生厅重点科研课题(200406)
参考文献14
-
1张捷,陈晓华.KAI_1在原发性肝癌组织中的表达水平及调控机制的初探[J].中国实验诊断学,2003,7(3):234-237. 被引量:4
-
2张卫国,王一,吴伟清,冼志红,关新元,吴孟超.KAI1/CD82蛋白表达与肝细胞癌侵袭转移[J].中华普通外科杂志,2002,17(9):539-541. 被引量:8
-
3汤钊猷.试论原发性肝癌复发转移的研究[J].中华实验外科杂志,1999,16(6):485-486. 被引量:20
-
4曾益新主编.肿瘤学[M]. 人民卫生出版社, 1999
-
5Zhang XA,Bo He,Bin Zhou,et al.Requiremnet of the P130[s-up CAS]-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration[].Journal of Biological Chemistry.2003
-
6Dong JT,Lamb PW,Rinker Schaeffer CW,et al.KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2[].Science.1995
-
7Mashimo T,Watabe M,Hirota S,et al.The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53[].Proceedings of the National Academy of Sciences of the United States of America.1998
-
8Jackson P,Grimm MO,Kingsley EA,et al.Relationship between expression of KAI1 metastasis suppressor gene, mRNA levels and p53 in human bladder and prostate cancer cell lines[].Urologic Oncology.2002
-
9Zhang XA,Lane WS,Charrin S,et al.EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells[].Cancer Research.2003
-
10Schoenfeld N,Bauer MK,Grimm S.The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates[].FASEB Journal The.2004
二级参考文献12
-
1Lebel BS, Gli ML, Lagaudriere C, et al. Futher characterization of CD82/IA4 angen( type Ⅲ surface protein):an activation/differentiation marker of mononuciear cells[J]. Cell Immunol, 1994. 154( 1 ) :468.
-
2Dong JT, Lamb PW, Rinker Schaeffer CW, et al. KAI1 a metaslasis supressor gene for prostate cancer on human chromosome llpll 2[J] .Science, 1995,268(5212) :884.
-
3Mancini DN. Singh SM, Archer TK, et al. Site-specific DNA emthvlation I the neurofibromatosis( NFL)promoter interferes with binding of CREB and SPL transcription factor [J]. Oncogenc, 1999,18(28) :4108.
-
4Sun HC,Tang ZY,Zhou G,et al.KAI1 gene expression in hepatocellular carcinoma and its relationship with intrahepatic metastases[].Journal of Experimental and Clinical Cancer Research.1998
-
5Guo XZ,Friess H,DiMola FF,et al.KAI1, a new metastasis suppressor gene , is reduced in metastatic hepatocellular carcinoma[].Hepatology.1998
-
6Moch H,Schraml P,Bubendorf L,et al.High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma[].American Journal of Pathology.1999
-
7Tagawa K,Arihiro K,Takeshima Y,et al.Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma[].Japanese Journal of Cancer Research.1999
-
8Kononen J,Bubendorf L,Kallioniemi A,et al.Tissue microarrays for high throughput molecular profiling of tumor specimens[].Nature Medicine.1998
-
9Schraml P,Kononen J,Bubendorf L,et al.Tissue microarrays for gene amplification surveys in many different tumor types[].Clinical Cancer Research.1999
-
10张捷,邓蕾,寇丽筠.肝癌患者外周血中白蛋白mRNA检测及其临床意义[J].实用癌症杂志,2000,15(1):22-24. 被引量:1
共引文献27
-
1胡泽民,余元龙,常晓健,陈宏,周载平.中晚期肝癌切除后再以介入为主的综合治疗分析[J].岭南现代临床外科,2002,2(1):15-17.
-
2段光杰,阎晓初.组织芯片在消化道肿瘤病理研究中的应用进展[J].消化外科,2004,3(4):301-304. 被引量:3
-
3朱虹,陈孝平.原发性肝癌转移和复发的分子机制及治疗的研究进展[J].中华肝胆外科杂志,2004,10(1):68-70. 被引量:9
-
4张卫国,王一,吴伟清,冼志红,关新元,吴孟超.MRP1/CD9蛋白在人肝细胞癌中的表达及其意义[J].中国普通外科杂志,2005,14(2):104-107. 被引量:3
-
5张水军,张弓,赵永福,李捷,屈清荣,李星.EphA2在原发性肝细胞癌中的表达及临床意义[J].中华实验外科杂志,2006,23(3):269-270. 被引量:8
-
6荚卫东,孙惠川,薛琼,钱永兵,刘银坤,汤钊猷.利用噬菌体肽库筛选高转移潜能人肝癌细胞结合肽[J].中华实验外科杂志,2006,23(3):276-278. 被引量:5
-
7朱求实,冯贤松.肝癌复发的分子标记物研究现状[J].中华外科杂志,2006,44(15):1065-1067. 被引量:4
-
8童海东.经皮穿刺肝动脉化疗栓塞治疗原发性肝癌疗效评价[J].医用放射技术杂志,2006(10):76-77.
-
9马毅,何晓顺,陈规划.肝癌肝移植术后肿瘤的复发及有效干预研究进展[J].中华实验外科杂志,2007,24(2):254-256. 被引量:12
-
10傅军,高涌.组织芯片技术及其在肝癌研究中的应用[J].蚌埠医学院学报,2007,32(2):244-246.
-
1季润元,冯振卿.KAI1基因与肿瘤侵袭、转移、预后的关系[J].医学研究生学报,2004,17(10):949-951. 被引量:7
-
2朱林静,来翀,胡虎.TM4SF与整合素共同调节肿瘤转移[J].浙江大学学报(医学版),2009,38(2):208-214. 被引量:2
-
3雷印胜,韩春生,邵军.CD82的表达与非小细胞肺癌的预后[J].国外医学(肿瘤学分册),1999,26(4):229-231.
-
4李珊珊.TM4SF的生物学功能及肿瘤转移抑制作用[J].国外医学(肿瘤学分册),1997,24(5):283-285. 被引量:3
-
5方婷婷,刘彬彬.四次跨膜超家族蛋白3在肿瘤中的研究进展[J].医学综述,2015,21(5):814-816.
-
6顾婷婷,陈莉.肿瘤相关基因NET-1的研究进展[J].现代肿瘤医学,2016,24(12):1999-2002. 被引量:10
-
7宋晓花,耿佃忠,王霞.肿瘤相关基因NET-1的研究进展[J].实用医学杂志,2008,24(2):169-171.
-
8任丽楠,刘民培,郭晓钟,徐建华,安天义.KAI1基因在胰腺癌中抗转移作用的研究[J].世界华人消化杂志,2003,11(7):1046-1049. 被引量:4
-
9石刚,董明.四跨膜蛋白超家族在消化系统恶性肿瘤中的生物学行为的研究进展[J].中国普外基础与临床杂志,2014,21(9):1173-1178. 被引量:2
-
10夏志军,张淑兰.KAIl基因与恶性肿瘤浸润相关性的研究[J].国外医学(妇幼保健分册),2003,14(6):439-443.